• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Corrigendum re "Impact of Body Mass Index on Survival Outcomes for Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis" [Eur Urol Open Sci 2022;39:62-71].关于“体重指数对免疫肿瘤学时代转移性肾细胞癌患者生存结局的影响：一项系统评价和荟萃分析”的勘误[《欧洲泌尿外科开放科学》2022年；39:62 - 71]
Eur Urol Open Sci. 2022 Dec 19;48:17. doi: 10.1016/j.euros.2022.12.001. eCollection 2023 Feb.
2
Corrigendum re "Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?" [Eur Urol Open Sci 2020;22:9-16].关于“前列腺癌术后大分割放疗：该领域是否已准备好？”[《欧洲泌尿外科开放科学》2020年；22:9 - 16]的勘误
Eur Urol Open Sci. 2022 Aug 27;44:52-53. doi: 10.1016/j.euros.2022.08.012. eCollection 2022 Oct.
3
Corrigendum re "Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer" [Eur Urol Open Sci 2021;34:17-18].关于“高危前列腺癌的初始分期应采用前列腺特异性膜抗原正电子发射断层扫描，而非传统成像”[《欧洲泌尿外科开放科学》2021年；34:17 - 18]的勘误
Eur Urol Open Sci. 2022 Apr 4;39:47. doi: 10.1016/j.euros.2022.03.008. eCollection 2022 May.
4
Corrigendum to "Rectal Perforation During Pelvic Surgery" [Eur Urol Open Sci 44 (2022) 54-59].《盆腔手术中直肠穿孔》的勘误[《欧洲泌尿外科开放科学》44 (2022) 54 - 59]
Eur Urol Open Sci. 2023 Jan 20;49:10. doi: 10.1016/j.euros.2023.01.001. eCollection 2023 Mar.
5
Corrigendum to "RPN (Radius, Position of tumour, iNvasion of renal sinus) Classification and Nephrometry Scoring System: An Internationally Developed Clinical Classification To Describe the Surgical Difficulty for Renal Masses for Which Robotic Partial Nephrectomy Is Planned" [Eur. Urol. Open Sci. 54 (2023) 33-42].《RPN（肿瘤半径、位置及肾窦侵犯）分类与肾计量评分系统：一项国际制定的临床分类，用于描述计划行机器人辅助部分肾切除术的肾肿物手术难度》的勘误 [《欧洲泌尿外科开放科学》54卷（2023年）第33 - 42页]
Eur Urol Open Sci. 2024 Mar 16;63:2-3. doi: 10.1016/j.euros.2024.03.001. eCollection 2024 May.
6
Corrigendum to "Clinical Trial Protocol: Developing an Image Classification Algorithm for Prostate Cancer Diagnosis on Three-dimensional Multiparametric Transrectal Ultrasound" [Eur. Urol. Open Sci. 49 (2023) 32-43].《“临床试验方案：开发用于三维多参数经直肠超声前列腺癌诊断的图像分类算法”的勘误》[《欧洲泌尿外科开放科学》49卷（2023年）第32 - 43页]
Eur Urol Open Sci. 2023 Jun 20;54:65. doi: 10.1016/j.euros.2023.06.001. eCollection 2023 Aug.
7
Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis.体重指数对免疫肿瘤学时代转移性肾细胞癌患者生存结局的影响：一项系统评价和荟萃分析
Eur Urol Open Sci. 2022 Apr 4;39:62-71. doi: 10.1016/j.euros.2022.03.002. eCollection 2022 May.
8
Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006: Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?回复：森庆一郎、穆罕默德·阿布法拉吉、哈迪·莫斯塔菲等人。程序性死亡配体1在接受免疫检查点抑制剂治疗的转移性肾细胞癌患者中的预测价值：一项系统评价和荟萃分析。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.10.006：免疫检查点抑制剂的临床活性：宿主是答案吗？
Eur Urol. 2021 Apr;79(4):e112. doi: 10.1016/j.eururo.2021.01.013. Epub 2021 Jan 29.
9
Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?回复约翰娜·诺埃尔、奥利维耶·于利亚尔和弗朗索瓦·戈德瓦塞尔致编辑的信，信的内容涉及：森英一郎、穆罕默德·阿布法拉吉、哈迪·莫斯塔菲等人的《程序性死亡配体1在接受免疫检查点抑制剂治疗的转移性肾细胞癌患者中的预测价值：一项系统评价和荟萃分析》。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.10.006。免疫检查点抑制剂的临床活性：宿主是答案吗？
Eur Urol. 2021 Apr;79(4):e113-e114. doi: 10.1016/j.eururo.2021.01.012. Epub 2021 Jan 21.
10
Re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002.回复：罗汉恩·J.M.·科雷亚、亚历山大·V.·路易、尼古拉斯·G.·扎尔斯基等。立体定向消融放疗在原发性肾细胞癌中的新兴作用：一项系统评价和荟萃分析。《欧洲泌尿外科聚焦》。即将发表。https://doi.org/10.1016/j.euf.2019.06.002 。
Eur Urol Focus. 2021 Mar;7(2):406. doi: 10.1016/j.euf.2019.08.018. Epub 2019 Sep 26.

关于“体重指数对免疫肿瘤学时代转移性肾细胞癌患者生存结局的影响：一项系统评价和荟萃分析”的勘误[《欧洲泌尿外科开放科学》2022年；39:62 - 71]

Corrigendum re "Impact of Body Mass Index on Survival Outcomes for Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis" [Eur Urol Open Sci 2022;39:62-71].

作者信息

Takemura Kosuke, Yonekura Satoru, Downey Laura E, Evangelopoulos Dimitris, Heng Daniel Y C

机构信息

School of Public Health, Imperial College London, London, UK.

Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.

出版信息

Eur Urol Open Sci. 2022 Dec 19;48:17. doi: 10.1016/j.euros.2022.12.001. eCollection 2023 Feb.

DOI:10.1016/j.euros.2022.12.001
PMID:36583180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9793202/
Abstract

[This corrects the article DOI: 10.1016/j.euros.2022.03.002.].

摘要

[本文更正了文章的数字对象标识符：10.1016/j.euros.2022.03.002。]